Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

80.61
-4.3000-5.06%
Post-market: 81.150.5400+0.67%19:54 EDT
Volume:1.41M
Turnover:113.93M
Market Cap:3.93B
PE:-18.65
High:85.17
Open:84.89
Low:79.77
Close:84.91
52wk High:151.02
52wk Low:44.42
Shares:48.77M
Float Shares:29.72M
Volume Ratio:1.47
T/O Rate:4.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3223
EPS(LYR):-3.7900
ROE:-1433.70%
ROA:-25.78%
PB:-307.57
PE(LYR):-21.27

Loading ...

Celcuity Q2 Adjusted EPS USD -1.07 Vs. IBES Estimate USD -1.16

Reuters
·
Aug 14

Celcuity Q2 Adjusted EPS USD -1.07 VS. Ibes Estimate USD -1.16

THOMSON REUTERS
·
Aug 14

Press Release: Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Celcuity to Report Q2 Results, Host Webcast Call

Reuters
·
Aug 06

Celcuity announces NCCN recommendation for Revtorpyk combination

TIPRANKS
·
Jul 30

Celcuity Says NCCN Guidelines Add Newly FDA-approved Revtorpyk for Advanced Hr+/her2- Breast Cancer

Reuters
·
Jul 30

Celcuity - FDA Approves Revtorpyk for Hr+/Her2- Advanced Breast Cancer Without Pik3CA Mutation on July 14, 2026

THOMSON REUTERS
·
Jul 30

Newly FDA-Approved Revtorpyk™ (Gedatolisib) Included in the National Comprehensive Cancer Network® (Nccn®) Clinical Practice Guidelines for Hr+/Her2- Locally Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
Jul 30

Celcuity - Revtorpyk Expected to be Commercially Available in U.S. in Late Q3 2026

THOMSON REUTERS
·
Jul 30

Faeth Therapeutics' Experimental Cancer Drug Piktor Has Upside Potential, Oppenheimer Says

MT Newswires Live
·
Jul 28

U.S. Research ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics

Reuters
·
Jul 27

Celcuity Inc : Leerink Partners Raises Target Price to $148 from $147

THOMSON REUTERS
·
Jul 27

3 Stocks With Healthy Growth Potential Investors Should Watch

Simply Wall St.
·
Jul 19

Celcuity (CELC) Receives a Buy from Leerink Partners

TIPRANKS
·
Jul 17

3 High Growth Commodity Stocks With Healthy Balance Sheets

Simply Wall St.
·
Jul 17

Baker Bros. Advisors Reports Celcuity Share Disposal Worth $317.5 Million

Reuters
·
Jul 17

Celcuity Shares Fall as Launch Delay Eclipses US Approval for Breast Cancer Drug

Reuters
·
Jul 15

Analysts’ Top Healthcare Picks: Denali Therapeutics (DNLI), Celcuity (CELC)

TIPRANKS
·
Jul 15

Celcuity falls -12.6%

TIPRANKS
·
Jul 15